GlassScriptPhysician profile
Matthew A Hicks
NPI 1508307646
$9,832.61
in general payments reported to CMS, 2019-2025
34 companies · $5,332 in 2025
The $5,332 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2022: $847 · 2023: $859 · 2024: $2,484 · 2025: $5,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,914 · Consulting Fee: $2,635 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,914.12 |
| Consulting Fee | $2,635.00 |
| Education | $125.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $3,379.80 | 2022-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $1,108.38 | 2022-2025 | Airsupra, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $773.67 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Abbott Laboratories | $623.88 | 2023-2025 | 2nd Gen Centrimag Primary Console |
| Abiomed | $581.07 | 2024-2025 | Impella |
| Genzyme Corporation | $579.87 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $386.24 | 2019-2025 | Zerbaxa, Winrevair, Keytruda |
| Inari Medical, INC. | $300.83 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| United Therapeutics Corporation | $261.22 | 2023-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $227.68 | 2024-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.40 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Amgen INC. | $198.75 | 2024-2025 | Tezspire |
| Pulmonx Corporation | $134.51 | 2022 | |
| Penumbra, INC. | $125.00 | 2023 | Indigo System |
| Baxter Healthcare | $122.03 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $113.39 | 2024-2025 | Opsumit, Uptravi, Opsynvi |
| Sanofi-Aventis U.S. LLC | $99.95 | 2024 | |
| Mylan Specialty L.P. | $71.22 | 2024 | Yupelri |
| Allergan, INC. | $70.12 | 2019 | |
| Grifols USA, LLC | $66.33 | 2024-2025 | Prolastin-C Liquid |
| Pfizer INC. | $55.85 | 2019-2025 | |
| Abbvie INC. | $45.31 | 2024-2025 | |
| Tactile Systems Technology INC | $38.61 | 2025 | Nimbl, Flexitouch Plus |
| Ani Pharmaceuticals, INC. | $36.69 | 2024 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $32.71 | 2025 | Yupelri |
| Sandoz INC. | $28.29 | 2024 | Treprostinil |
| Mallinckrodt Hospital Products INC. | $28.05 | 2024 | Acthar |
| Vifor Pharma, INC. | $25.26 | 2024 | Zemaira |
| Ethicon INC. | $24.79 | 2025 | Monarch Platform |
| La Jolla Pharmaceutical Company | $22.41 | 2025 | Giapreza |
| Verona Pharma, INC. | $20.40 | 2025 | Ohtuvayre |
| Phadia US INC. | $16.30 | 2025 | Immunocap |
| Alexion Pharmaceuticals, INC. | $15.83 | 2023 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $14.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.